In subjects with essential hypertension, angiotensinconverting enzyme (ACE) inhibition increases arterial diameter, compliance and distensibility of peripheral muscular arteries in association with blood pressure reduction. Whether pulse pressure amplification is modified by ACE inhibition and whether changes in compliance and distensibility are due to a drug effect on the arterial wall, to the blood pressure reduction or to a combination of both factors, is largely ignored. In a randomised, double-blind crossover trial, we used the ACE inhibitor quinapril as a marker to evaluate the changes in: pulse pressure amplification (applanation tonometry), carotid compliance and distensibility (echotracking technique), and aortic distensibility (measured from pulse wave velocity). Quinapril decreased in the same extent carotid and brachial pulse pressure, thus causing a resetting of pulse pressure amplification
Introduction
Both experimental and clinical studies indicate that large arteries respond actively to anti-hypertensive agents. 1 However, in clinical situations, the evaluation of the arterial response remains difficult to elucidate, requiring either invasive investigations in a small number of subjects 2 or atraumatic procedures with highly reproducible, but time consuming, techniques. Thus it is important to develop methods which may be routinely performed for the investigations of large arteries in cardiovascular pharmacology.
Pulse pressure amplification is of major interest to evaluate the status of the arterial tree. 3 Whereas mean arterial pressure is practically identical along the arterial system, pulse pressure increases markedly from central to peripheral arteries, making that the degree of pulsatile stress differs markedly from one artery to another one. Because increased brachial pulse pressure has been shown to be an independent predictor of cardiac mortality, principally toward normal values. Carotid compliance and distensibility as well as aortic distensibility increased significantly. Based on three-way analysis of variance, it was shown that, whereas the changes in carotid stiffness were exclusively due to blood pressure reduction and not to a drug-induced relaxation of the arterial wall, the changes in aortic distensibility were due to the combination of both factors. Thus, using an atraumatic noninvasive procedure, it was possible to show that: (i) ACE inhibition is able to maintain pulse pressure amplification, an important factor contributing to reduce the afterload of the heart; and (ii) ACE inhibition alters the hypertensive arterial wall in a very heterogeneous manner, with a maximal drug effect on muscular large arteries like the abdominal aorta, and not on elastic arteries like the carotid artery and the thoracic aorta.
for myocardial infarction, [4] [5] [6] it is of major importance to also measure aortic pulse pressure, a major component of cardiac after load. Indeed, increased aortic pulse pressure in old people is due both to an increase in systolic pressure, which favours cardiac hypertrophy and to a decrease in diastolic blood pressure (DBP), which alters coronary perfusion. Thus it is relevant, using the non-invasive method of applanation tonometry, 7 to determine pulse pressure in various arterial sites, and particularly at the site of the thoracic aorta.
Another point to consider in cardiovascular pharmacology is to determine whether the arterial effects observed under treatment are a passive consequence of the pressure effect, or due to a direct drug effect on the arterial wall or to a combination of both factors. 1 Studies in untreated subjects with essential hypertension indicate that the decreased compliance observed in hypertensive subjects may be the simple consequence of the elevated BP in some arterial segments, like the common carotid artery, or may be strongly influenced by the structure of the arterial wall, as recently shown for the femoral artery. 8, 9 This problem requires that, in cardiovascular clinical trials, sophisticated statistical analysis may be performed, enabling simultaneous evalu-ation of the drug effect, of the pressure effect, and finally also taking into account the large heterogeneity of the various segments of the arterial tree. Statistical analysis, enabling the discrimination between such varieties of responses, have been widely developed. 10 The objective of the present study was, using the angiotensin-converting enzyme (ACE) inhibitor, quinapril, 11 as a marker in subjects with essential hypertension, to develop accurate and simple methods enabling us to evaluate pulse pressure amplification and changes in the stiffness of the aorta and the carotid artery following drug treatment.
Patients and methods

Patients
Twenty patients (12 men and eight women) with essential hypertension completed this study. Mean age (± 1 s.d.) was 53 ± 10 years (range 39 to 70). Mean weight was 73 ± 11 kg and mean height 171 ± 7 cm. All subjects had mild to moderate hypertension according to World Health Organization criteria. All drugs treatment were stopped at least 1 month before the study. DBP measured by sphygmomanometer after a 2-week placebo period was above 95 mm Hg. Extensive clinical and biological investigations were performed, according to previously described procedures, 12 indicating that patients had essential hypertension without cardiac, neurologic or renal involvement, arteriosclerosis obliterans of the lower limbs, or diabetes mellitus. Written informed consent was obtained from patients. The study was approved by the Ethical Committee of St Germain en Laye (Ile de France). Patients participated in a randomised, double-blind, crossover study. After a 1-month wash-out and 2-week placebo periods, patients were randomised into two groups. Subjects in group A received a single acute oral dose of quinapril (20 mg), whereas subjects in group B received identical tablets of placebo. Then all patients received placebo for another 2-week period at the end of which the acute treatment was changed, with patients in group A receiving placebo and those in group B receiving quinapril. Haemodynamic determinations were performed at the end of each placebo period, before, and 2 h after each acute single oral administration.
Brachial and ankle BP measurements
The haemodynamic study was performed during a day hospitalisation, at a controlled room temperature of 20-23°C, and after a 30-min rest. Subjects were recumbent during the investigation. First, brachial BP was measured according to the WHO recommendation using a mercury sphygmomanometer and an oscillometric BP recorder. Secondly, brachial and ankle systolic BP (SBP) were determined using the Doppler method. 12 Brachial, systolic, diastolic and mean arterial pressure, and the heart rate, were measured automatically on the left arm using an automatic oscillometric BP recorder (Dinamap type 845, Tampa, FL, USA). Measurements were taken every 3 min for 30 min. For the individual evaluation of brachial and ankle SBP, the two parameters were measured on the right and left sides using a pressure cuff of appropriate diameter, a standard mercury sphygmomanometer, and a Doppler probe, according to the technique described by Yao et al. 13 Brachial SBP was recorded as the appearance of an audible sound. Ankle SBP was determined by a pressure cuff applied snugly above the malleolus. The cuff was inflated to a pressure exceeding the brachial SBP by about 40-50 mm Hg and the systolic pressure was determined by the reappearance of the pulse (an audible Doppler sound). According to the requirements of this technique, none of the limbs presented an incompressible arterial syndrome. Three measurements were performed on each side, and the mean value was taken to calculate the ankle on brachial SBP ratio. No significant difference was observed between the right and the left sides. A complete Doppler investigation, which involved all the leg arteries from the iliac to the ankle arteries, did not detect any significant stenosis of the lower limbs. 14 Carotid-femoral pulse wave velocity, a classic index of arterial stiffness, was determined according to the foot-to-foot method. Transcutaneous Doppler flow velocity records were carried out simultaneously at the base of the neck over the common carotid artery and the right femoral artery in the groin with a nondirectional Doppler unit (Sega M842 8 Mhz, OR, USA) and a Gould 8188 recorder (Gould Electronique, Ballainvillier, France) at 100 or 200 mm/sec. The foot of flow wave was identified as the point of the beginning at the sharp systolic upstroke or as the tangent drawn to the last part of the preceding flow wave and to the upstroke of the next wave, and the foot wave was taken as the intersection point of these two lines. The time delay was measured between the feet of the flow wave recorded at these different points from 10 consecutive beats and designated as the pulse transit time (t). The distance travelled by the pulse wave was measured over the body surface with a tape measure as the distance between the recording sites (D). Pulse wave velocity was calculated as PWV = D/t. For the measurements of PWV between the base of the neck and the femoral artery, the distance from the suprasternal notch to the carotid was subtracted from the total distance to take into account the pulse travelling in the opposite direction. A similar procedure was used to measure carotid-radial pulse wave velocity, as previously described. 15 
Pulse wave velocity measurements
Evaluation of carotid wave reflections and pulse pressure
The aortic or central artery pulse pressure waveform in humans has been well characterised and generally shown to manifest an inflection point (P i ) that divides the pressure wave into an early and mid-to-late systolic peak (P pk ) (Figure 1) . 3 The measured pressure waveform represents the sum of both the forward or incident wave and the backward or reflected wave. P pk is taken to be the result of the reflected wave returning from peripheral site (or sites) and causing an increase of the pulse and the carotid artery SBP. A quantification of carotid wave reflections may be obtained in absolute value from the differences (P pk − P i ) (mm Hg), and in per cent when divided by pulse pressure (PP), expressed as an augmentation index. As previously demonstrated, 3 the time delay (⌬tp) from the foot of the pressure wave to the inflection point has been interpreted to represent the travel time of the pulse wave to reflecting site (or sites) and its return (Figure 1) . Study of the relationships between the aortic pressure waveform and aortic input impedance has shown that a larger secondary rise of pulse pressure is associated with an enhanced oscillatory impedance spectrum due to differences in the magnitudes of wave reflections or interaction of reflection for different sites, or both. 16 Carotid artery pressure waveform and amplitude were recorded non-invasively using the tonometer, a pencil-type probe incorporating a high fidelity Millar strain gauge transducer in the tip of the probe (model SPT-301, Millar Instruments, Houston, TX, USA). 17 The tonometer is internally calibrated (1 mV = 1 mm Hg) using a conventional Millar preamplifier (TCB-500, Millar Instruments). Waveforms were recorded on a Gould 8188 recorder (Gould Electronic) at 100 or 200 mm/sec. In the present study the carotid pressure wave contour was taken to be representative of the pressure wave contour in the ascending aorta and central arteries, since similar non-invasive carotid and invasive ascending aortic pulses in individual subjects have been reported. Tonometery was also used to evaluate brachial artery pulse pressure at the site of the anterior part of the elbow, the arm being maintained on an arm-rest. Applanation tonometry requires training to obtain accurate and adequate angulation between the probe and the vessel axis, because transducer movements caused by movements of the patient's or operator's hands, and finally by inappropriate hold-down pressure can alter the quality of the recording as described by Kelly et al. 17 Ten to 15 consecutive pulses were analysed for each subject. Figure 1 Contours of the carotid pressure waveform recorded at the speed of 100 mm/sec in hypertensive subject. PP: pulse pressure; P pk : mid-to-late systolic peak; P i : early inflection point; ⌬tp: travel time of the reflected wave.
3
Measurements of pulsatile changes in carotiddiameter
Vessel wall motion of the right common carotid artery (CCA) was measured using an echo-tracking system, already described elsewhere. 8, 18 This system enables us to assess transcutaneously the displacement of the arterial wall during the cardiac cycle and hence, the time dependent changes in the arterial diameter relative to its initial diameter at the start of the cardiac cycles. Based on the two-dimensional B-mode image, a TM line perpendicular to the artery was selected. The radio frequency signal of four to eight cardiac cycles were recorded, digitised and temporarily stored. When the M-mode image was displayed on the computer screen, two sample volumes selected under cursor control were positioned respectively on the anterior and posterior arterial walls. To overcome the possibility that nearby structures generating prominent echoes may temporarily enter the selected sample volumes, this obscuring the vessel wall signal, a Doppler tracking system was developed and allowed the vessel walls to be tracked from the two selected sample volumes. Using the displacement waveform of the anterior and posterior walls of the CCA, it is possible to determine the stroke change in diameter during systole in absolute (Ds − Dd) or relative [(Ds − Dd)/Dd] values (Ds: systolic diameter; Dd: diastolic diameter). Because the side of the measurements did not influence arterial dimension, all arterial dimensional data given in the present study were from the right CCA. Compliance was the ratio between (Ds − Dd) and carotid PP. Distensibility was the ratio between (Ds − Dd)/Dd and carotid PP. Carotid PP was measured from applanation tonometry.
Statistical evaluation
The statistical analysis was performed through SAS (Statistical Analysis System for Windows, release 6-10). Baseline values of groups A and B were compared with one-way analysis of variance, and did not show any difference. Haemodynamic and biological changes were studied by two-way analysis of variance for repeated measures applied to a crossover design and testing treatment and period effect. In order to verify that there was a different response in pulse pressure between site of measurements, a three-way analysis of variance (ie, subject, treatment, site) was performed with baseline values as covariates. In addition, since arterial haemodynamic parameters are influenced by BP level, we carried out a complementary analysis on carotid artery compliance, distensibility and carotid femoral PWV adjusted for BP at the time they were measured. This was done using an analysis of covariance for two within factors and two covariates: baseline value and a covariate changing with the pressure level at any given time (brachial mean BP measured at each time). A P value Ͻ0.05 was considered as significant. Figure 2 shows that brachial BP (systolic, diastolic, mean) decreased significantly under quinapril (P Ͻ 0.001) but not under placebo. Carotid-femoral and carotid-radial PWV also decreased significantly following quinapril (P Ͻ 0.001; P Ͻ 0.01). Table 1 shows the mean values of brachial SBP and tibial SBP before and after treatment by placebo or quinapril. A significant decrease of both the brachial and tibial SBP were noted under quinapril but their ratio did not change. Table 2 shows that both brachial and carotid pulse pressure decreased significantly (P Ͻ 0.05; P Ͻ 0.001) following quinapril. In baseline conditions, carotid pulse pressure was significantly lower (P Ͻ 0.025) than brachial pulse pressure (Tables 2 and 3) . Following quinapril, the decrease occurred in the same extent (Table 2 ) with no interaction between treatment and site of measurement. The effect of quinapril did not differ significantly between the two sites. In addition to the decrease in carotid PP following quinapril, there was a decrease in the amplitude of wave reflection (P pk − P i ) (P Ͻ 0.02) but no significant change in time delay (⌬tp) ( Table 2) . Table 4 shows that quinapril reduced carotid diastolic diameter (P Ͻ 0.02) and increased the per cent change in diameter (P Ͻ 0.05). Following quinapril, carotid distensibility and compliance increased significantly (P Ͻ 0.001; P Ͻ 0.01). Table 5 shows that, after adjustment of changes in compliance and distensibility according to their baseline values and BP level, no significant treatment effect was found on carotid compliance and distensibility when adjusted on these covariates. Conversely, even after adjustment, pulse wave velocity was found lower under quinapril than under placebo (Table 5) .
Results
Blood pressure and pulse wave velocity
Pulse pressure and tonometer changes
Arterial compliance and distensibility
Discussion
The major results of the present study were that, following the ACE inhibitor quinapril in patients with essential hypertension, (i) pulse pressure amplification was maintained but reset towards lower values of BP, and (ii) whereas the increase in carotid compliance and distensibility was related to BP reduction alone, the increase in aortic distensibility was mediated both by the drug effect and the BP reduction.
Pulse pressure amplification
Studies of pulsatile arterial haemodynamics have shown that, whereas mean arterial pressure remains 15 ± 9 1 0 ± 7 1 6 ± 10 15 ± 11 0.02 (P pk − P i )/PP (%)
(P pk − P i ), ⌬tp: see Figure 1 . practically unchanged along the arterial tree, pulse pressure increases markedly in proportion with the length of the arterial tree. This pulse pressure gradient is observed in both normotensive and hypertensive populations in which it develops in the same extent, 1 as confirmed in the present study. Because pulse pressure amplification is the consequence of the progressive decrease in the crosssectional area and an increase in stiffness of large arteries, and because this haemodynamic pattern is largely influenced by the timing of wave reflections, it is logical to expect that vasodilating compounds might modify pulse pressure amplification. Nitrates, for instance, decrease more central than peripheral pulse pressure, thus modifying markedly pressure wave transmission and amplification. 3 In the present study, we observed that carotid pulse pressure decreased significantly following quinapril. However, the decrease occurred in the same extent in central and peripheral arteries, making that the pulse pressure gradient was simply shifted toward lower values of BP.
Because the changes in pulse pressure are mainly determined by those of SBP, we used the simultaneous measurements of brachial and ankle SBP as another simple marker of pressure wave transmission. We observed that the ratio between ankle and brachial SBP did not differ with quinapril, indicating that a simple shift of pulse pressure amplification occurred following quinapril.
It should be noticed that the result should be limited to the present population for two reasons. Firstly, due to the influence of age on the timing of wave reflections, the pulse pressure amplification disappears in an aged population. 3 In the present study, the age range was wide (39 to 70 years), and it is possible that different findings may have been observed in a more homogeneous population of old subjects. Secondly, in populations of patients with hypertension and end-stage renal disease, in which carotid and peripheral pulse pressure have been found equal, ACE inhibition decreased more carotid than brachial pulse pressure. 19 The same pattern has been observed in rats with spontaneous genetic hypertension, in which carotid and femoral pulse pressure are equal in the absence of treatment. Following ACE inhibition or calcium blockade, but not following dihydralazine, the pulse pressure gradient is restored, as it is normally observed in untreated normotensive control rats.
20,21
Quinapril-induced effect on arterial wall stiffness In a previous study based on carotid artery in situ preparation from spontaneously hypertensive rats, 22 we showed that quinapril increased the in vivo compliance of the arterial wall in the absence of change of systemic BP. Because the carotid artery in rats is rather a musculo-elastic artery, the compliance enhancement was more pronounced in the presence of BP reduction. These results are difficult to extrapolate to hypertensive humans, because the human common carotid artery is more elastic than that of hypertensive rats and contains less vascular smooth muscle. In the present study, quinapril tended to decrease passively carotid diameter, as a mechanical consequence of the BP reduction itself. For the increase in carotid compliance under ACE inhibition, the role of the BP reduction itself has been shown to be largely predominant in older subjects with systolic hypertension. 23 Nevertheless, several studies in hypertensive subjects indicated that, in middle age, ACE-inhibition caused a druginduced increase in arterial compliance independent of its anti-hypertensive effect. 24, 25 Such findings were observed mainly with long term, and not acute treatment, like in the present study, and by comparison to other anti-hypertensive compounds, but not to placebo.
In the present study, hypertensive subjects were of middle age and the investigation was performed acutely and compared with placebo. Because the carotid and the aortic walls are quite heterogeneous in humans and because the pharmacological effects on the arterial wall may differ markedly from one site to another of the arterial tree, we evaluated the effect of quinapril separately on carotid and carotidfemoral distensibility. The latter measurement was obtained from the determination of pulse wave velocity. Based on a three-way analysis of variance, we showed that, whereas the increase in carotid distensibility was exclusively related to the BP reduction, no comparable finding was observed for carotid-femoral pulse wave velocity, ie, the decrease in pulse wave velocity was due both to a pressure effect and to a drug effect.
For the understanding of the present result, it is important to recall that, whereas the carotid artery and the thoracic aorta are predominant elastic arteries, which are markedly influenced by BP changes, the abdominal aorta is much more muscular and reacts actively to vasoactive stimuli as those induced by converting enzyme inhibition. 1, 3 Nevertheless, although the increase in carotid compliance was mainly due to a BP reduction, this change was mainly related to a decrease in pulse pressure and thus to a delay in wave reflections [as shown from the decrease in (P pk − P i )]. This change in wave reflections indirectly reflects a drug-induced effect on the large artery wall. Indeed London et al 10 have recently shown that, following an acute single administration of quinapril in hypertensive patients with end-stage renal disease, the augmentation index (P pk − P i ) decreases independently of BP reduction itself. From these findings, the effect of quinapril on wave reflections was attributed to a drug-dilating effect on medium size muscular conduit arteries, as previously published for nitrates. 2, 3 In conclusion, the present study has shown that adequate non-invasive methods are now able to evaluate precisely the respective contribution of drug-induced and BP reduction effects on the arterial wall in different sites of the arterial tree. In hypertensive subjects, the determination of pulse pressure amplification and arterial stiffness and distensibility may be of major interest to evaluate the effects of antihypertensive agents on large arteries and their consequences on the heart.
